Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
3.840
+0.050 (1.32%)
At close: Aug 4, 2026, 4:00 PM EDT
3.830
-0.010 (-0.26%)
Pre-market: Aug 5, 2026, 4:01 AM EDT
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.37 billion as of August 5, 2026. Its market cap has decreased by -50.19% in one year.
Market Cap
1.37B
Enterprise Value
2.76B
1-Year Change
-50.19%
Ranking
Category
Stock Price
$3.84
ChartMarket Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.37B, an increase of 349.82%. That is a compound annual growth rate of 29.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 1.37B | -14.65% |
| Dec 31, 2025 | 1.61B | -59.76% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HUTCHMED (China) | 2.04B |
| ANI Pharmaceuticals | 1.70B |
| Trulieve Cannabis | 1.65B |
| Phibro Animal Health | 1.51B |
| Perrigo Company | 1.48B |
| Xeris Biopharma Holdings | 1.47B |
| Harrow | 1.46B |
| Eton Pharmaceuticals | 1.24B |